Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial
Guardado en:
Autores principales: | Erwin Birnie, Cornelis Verhoef, Reno Debets, Taco M A L Klem, Adriaan Moelker, Elles M F van de Voort, Gerson M Struik, Linetta B Koppert, Glenn Yo, Maura J P V Macco, Renata H J A Sinke, Martine Franckena |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1a32d624289742f98c3c80a9d7b99d5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ross for Valve replacement In AduLts (REVIVAL) pilot trial: rationale and design of a randomised controlled trial
por: PJ Devereaux, et al.
Publicado: (2021) -
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials
por: Giuseppe Cabibbo, et al.
Publicado: (2021) -
GESAP trial rationale and methodology: management of patients with suspected obstructive sleep apnea in primary care units compared to sleep units
por: Núria Tarraubella, et al.
Publicado: (2017) -
A cluster randomized controlled trial to evaluate the effects of a community health worker based approach to promote cardiovascular risk factor control in India: study design and rationale
por: Aditya Khetan, et al.
Publicado: (2016) -
A new agent for the treatment of noninfectious uveitis: rationale and design of three LUMINATE (Lux Uveitis Multicenter Investigation of a New Approach to Treatment) trials of steroid-sparing voclosporin
por: Eddy Anglade, et al.
Publicado: (2008)